400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
ChiCTR-IOR-15007465
正在进行
/
/
/
2015-11-25
/
/
愛滋病病毒感染者
以基因亞型指導低劑量依法韋侖在華裔愛滋病病毒感染者的臨床應用
以基因亞型指導低劑量依法韋侖在華裔愛滋病病毒感染者的臨床應用
以基因亞型指導低劑量依法韋侖在華裔愛滋病病毒感染者的臨床應用
随机交叉对照
Ⅳ期
simple randomization
/
The Chinese University of Hong Kong
/
50
/
1990-01-01
1990-01-01
/
1) HIV-infected adults older than 18 years old; 2) Stable CD4 T-cell counts (over 200 cells per uL) and undetectable viral load (plasma HIV-1 RNA < 75 copies per mL); 3) on HAART containing standard dose EFV and 2 nucleoside/nucleotide reverse transcriptase inhibitors (e.g. tenofovir and emtricitabine).;
请登录查看1) pregnant or nursing mothers; 2) have concurrent opportunistic infection or malignant disease, or any AIDS-defining illness; 3) on treatment or prophylaxis for an opportunistic infection; 4) have inadequate renal function (estimated creatinine clearance of <50 mL/min) or significantly deranged laboratory tests (e.g. ALT 1.5*upper limit of normal); 5) have documented non-adherence to study medications or HAART or documented history of illicit substance abuse; 6) illiterate or unable to communicate with study team; or 7) unable or refuse to participate or give consent.;
请登录查看School of Pharmacy, Chinese University of Hong Kong
/
英百瑞生物2025-12-05
艾力斯医药科技2025-12-05
神曦生物NeuExcell2025-12-05
科望医药2025-12-05
宠药生态圈2025-12-05
丁香园 Insight 数据库2025-12-05
佰傲谷BioValley2025-12-05
药精通Bio2025-12-05
医药观澜2025-12-05
贝达药业2025-12-05